Decision-making for Adjuvant Chemotherapy in the Absence of Genomic Testing for Breast Cancer Patients with ‘Intermediate’ Risk of Mortality at 10 Years. - Alrifai, D.; Harper-Wynne, C.; Jyothirmayi, R.; Burcombe, R. (Clinical Oncology, 2016)